sptan1 -照顾者调查结果。

IF 1.5 4区 医学 Q2 PEDIATRICS
Michelle Wilson, Francis Wong
{"title":"sptan1 -照顾者调查结果。","authors":"Michelle Wilson, Francis Wong","doi":"10.1089/cap.2024.0100","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> <i>SPTAN1</i> variants are thought to affect the scaffolding that protects the axonal segment of neurons as well as neuronal synapses. The <i>SPTAN1</i> gene is located in the 9q34.11 genomic region and encodes the cytoskeletal protein alpha II spectrin. Epilepsy, encephalopathy, and motor neuropathy are most commonly associated with <i>SPTAN1</i> variants. <b><i>Methods:</i></b> An informed consent and questionnaire were developed in order to gather information from caregivers regarding their family members' <i>SPTAN1</i> variant. Survey results are summarized descriptively, in order of frequency. <b><i>Results:</i></b> The results of a questionnaire filled out by the caregivers of loved ones who have a <i>SPTAN1</i> mutation are summarized for 25 individuals, 14 males and 11 females, who have the <i>SPTAN1</i> mutation. <b><i>Conclusions:</i></b> The results of this survey mirror those reported by other authors and include epilepsy, intellectual and motor delays, encephalopathy, and motor neuropathy. Additional effects of the <i>SPTAN1</i> mutation reported here include absent or difficult speech, happy personality, decline in cognitive and motor skills with age, vision and hearing abnormalities, organ and skeletal effects, autoimmune diseases, and weakened immune systems.</p>","PeriodicalId":15277,"journal":{"name":"Journal of child and adolescent psychopharmacology","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"<i>SPTAN1</i>-Results of a Caregiver Survey.\",\"authors\":\"Michelle Wilson, Francis Wong\",\"doi\":\"10.1089/cap.2024.0100\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> <i>SPTAN1</i> variants are thought to affect the scaffolding that protects the axonal segment of neurons as well as neuronal synapses. The <i>SPTAN1</i> gene is located in the 9q34.11 genomic region and encodes the cytoskeletal protein alpha II spectrin. Epilepsy, encephalopathy, and motor neuropathy are most commonly associated with <i>SPTAN1</i> variants. <b><i>Methods:</i></b> An informed consent and questionnaire were developed in order to gather information from caregivers regarding their family members' <i>SPTAN1</i> variant. Survey results are summarized descriptively, in order of frequency. <b><i>Results:</i></b> The results of a questionnaire filled out by the caregivers of loved ones who have a <i>SPTAN1</i> mutation are summarized for 25 individuals, 14 males and 11 females, who have the <i>SPTAN1</i> mutation. <b><i>Conclusions:</i></b> The results of this survey mirror those reported by other authors and include epilepsy, intellectual and motor delays, encephalopathy, and motor neuropathy. Additional effects of the <i>SPTAN1</i> mutation reported here include absent or difficult speech, happy personality, decline in cognitive and motor skills with age, vision and hearing abnormalities, organ and skeletal effects, autoimmune diseases, and weakened immune systems.</p>\",\"PeriodicalId\":15277,\"journal\":{\"name\":\"Journal of child and adolescent psychopharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of child and adolescent psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/cap.2024.0100\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of child and adolescent psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/cap.2024.0100","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:SPTAN1变异被认为影响保护神经元轴突段和神经元突触的支架。SPTAN1基因位于9q34.11基因组区,编码细胞骨架蛋白α II谱蛋白。癫痫、脑病和运动神经病变最常与SPTAN1变异相关。方法:制定知情同意书和问卷调查,以收集照顾者关于其家庭成员SPTAN1变异的信息。调查结果按频率顺序进行描述性总结。结果:对25例SPTAN1基因突变患者(男14例,女11例)进行问卷调查。结论:这项调查的结果与其他作者报道的结果一致,包括癫痫、智力和运动迟缓、脑病和运动神经病变。这里报道的SPTAN1突变的其他影响包括语言缺失或困难,性格开朗,随着年龄的增长认知和运动技能下降,视力和听力异常,器官和骨骼影响,自身免疫性疾病和免疫系统减弱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
SPTAN1-Results of a Caregiver Survey.

Background: SPTAN1 variants are thought to affect the scaffolding that protects the axonal segment of neurons as well as neuronal synapses. The SPTAN1 gene is located in the 9q34.11 genomic region and encodes the cytoskeletal protein alpha II spectrin. Epilepsy, encephalopathy, and motor neuropathy are most commonly associated with SPTAN1 variants. Methods: An informed consent and questionnaire were developed in order to gather information from caregivers regarding their family members' SPTAN1 variant. Survey results are summarized descriptively, in order of frequency. Results: The results of a questionnaire filled out by the caregivers of loved ones who have a SPTAN1 mutation are summarized for 25 individuals, 14 males and 11 females, who have the SPTAN1 mutation. Conclusions: The results of this survey mirror those reported by other authors and include epilepsy, intellectual and motor delays, encephalopathy, and motor neuropathy. Additional effects of the SPTAN1 mutation reported here include absent or difficult speech, happy personality, decline in cognitive and motor skills with age, vision and hearing abnormalities, organ and skeletal effects, autoimmune diseases, and weakened immune systems.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.60
自引率
5.30%
发文量
61
审稿时长
>12 weeks
期刊介绍: Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more. Journal of Child and Adolescent Psychopharmacology coverage includes: New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信